PALATINI, PIETRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.762
AS - Asia 1.807
EU - Europa 1.281
AF - Africa 450
SA - Sud America 387
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 23
Totale 10.759
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.530
SG - Singapore 577
CN - Cina 374
HK - Hong Kong 303
BR - Brasile 244
DE - Germania 169
FI - Finlandia 162
IT - Italia 115
VN - Vietnam 100
UA - Ucraina 96
SE - Svezia 83
GB - Regno Unito 78
FR - Francia 68
PL - Polonia 62
RU - Federazione Russa 58
NL - Olanda 43
PK - Pakistan 30
IN - India 27
MX - Messico 24
AE - Emirati Arabi Uniti 23
BE - Belgio 21
IQ - Iraq 21
SK - Slovacchia (Repubblica Slovacca) 21
TR - Turchia 21
RS - Serbia 20
IE - Irlanda 19
YT - Mayotte 19
CL - Cile 18
EG - Egitto 18
TN - Tunisia 18
UZ - Uzbekistan 18
YE - Yemen 18
AO - Angola 17
BO - Bolivia 17
CV - Capo Verde 17
PA - Panama 17
PY - Paraguay 17
SN - Senegal 17
AR - Argentina 16
CO - Colombia 16
PT - Portogallo 16
ZA - Sudafrica 16
BY - Bielorussia 15
CI - Costa d'Avorio 15
GR - Grecia 15
GT - Guatemala 15
PS - Palestinian Territory 15
TT - Trinidad e Tobago 15
AL - Albania 14
EE - Estonia 14
GP - Guadalupe 14
IR - Iran 14
MY - Malesia 14
NC - Nuova Caledonia 14
TH - Thailandia 14
UY - Uruguay 14
AM - Armenia 13
CZ - Repubblica Ceca 13
DJ - Gibuti 13
DK - Danimarca 13
GF - Guiana Francese 13
ID - Indonesia 13
JO - Giordania 13
KG - Kirghizistan 13
LB - Libano 13
ML - Mali 13
NO - Norvegia 13
RO - Romania 13
SI - Slovenia 13
TJ - Tagikistan 13
BB - Barbados 12
CD - Congo 12
CH - Svizzera 12
CR - Costa Rica 12
DZ - Algeria 12
EC - Ecuador 12
ET - Etiopia 12
HR - Croazia 12
HU - Ungheria 12
KZ - Kazakistan 12
MK - Macedonia 12
NP - Nepal 12
PH - Filippine 12
PR - Porto Rico 12
VE - Venezuela 12
BW - Botswana 11
BZ - Belize 11
CG - Congo 11
CW - ???statistics.table.value.countryCode.CW??? 11
DM - Dominica 11
GA - Gabon 11
GM - Gambi 11
GN - Guinea 11
KH - Cambogia 11
LU - Lussemburgo 11
MU - Mauritius 11
MZ - Mozambico 11
NE - Niger 11
NZ - Nuova Zelanda 11
RW - Ruanda 11
Totale 10.293
Salva come PNG Salva come JPEG
Città #
Fairfield 881
Woodbridge 776
Ann Arbor 648
Houston 551
Chandler 482
Ashburn 405
Jacksonville 374
Singapore 371
Wilmington 306
Hong Kong 285
Seattle 284
Cambridge 276
Santa Clara 166
Princeton 157
Boardman 138
San Diego 88
Beijing 86
Roxbury 83
Nanjing 64
Medford 54
Dong Ket 52
Helsinki 49
Padova 49
Bytom 46
Des Moines 40
Munich 39
Shenyang 31
Ho Chi Minh City 26
New York 25
Nanchang 23
Tianjin 20
Dakar 17
Hebei 17
São Paulo 17
Dublin 16
Norwalk 16
Panama City 16
Tashkent 16
Abidjan 15
Chicago 15
Jinan 15
London 15
Guangzhou 14
Los Angeles 14
Noumea 14
Praia 14
Bamako 13
Bishkek 13
Guatemala City 13
Luanda 13
Montevideo 13
Amman 12
Bridgetown 12
Turku 12
Athens 11
Conakry 11
Djibouti 11
Dushanbe 11
Hefei 11
Kampala 11
Kigali 11
Mamoudzou 11
Phnom Penh 11
Yerevan 11
Bangkok 10
Hanoi 10
Kinshasa 10
Libreville 10
Managua 10
Maputo 10
Niamey 10
Salt Lake City 10
Tallinn 10
Baghdad 9
Banjul 9
Brooklyn 9
Buffalo 9
Changsha 9
Cotonou 9
Detroit 9
Havana 9
Kuala Lumpur 9
Ljubljana 9
Lusaka 9
Pristina 9
Rawalpindi 9
Redwood City 9
Rio de Janeiro 9
Saarbrücken 9
San José 9
Sanaa 9
Tirana 9
Ulan Bator 9
Accra 8
Aden 8
Baku 8
Belgrade 8
Belo Horizonte 8
Boston 8
Cayenne 8
Totale 7.643
Salva come PNG Salva come JPEG
Nome #
Severe Liver Cirrhosis Markedly Reduces AhR-Mediated Induction of Cytochrome P450 in Rats by Decreasing the Transcription of Target Genes 208
Biological and pharmacological properties of phospholipids. 205
In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: A comparison with human liver microsomes 191
Expression and distribution of the adrenomedullin system in newborn human thymus. 175
Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes 175
A comparison between different methods for the determination of reduced and oxidized glutathione in mammalian tissues 171
Coadministration of sirolimus alters tacrolimus pharmacokinetics. 170
Flavonoids diosmetin and hesperetin are potent inhibitors of cytochrome P450 2C9-mediated drug metabolism in vitro. 163
An intracellular adrenomedullin system reduces IL-6 release via a NF-kB-mediated, cAMP-independent transcriptional mechanism in rat thymic epithelial cells 160
Effect of age on single- and multiple-dose pharmacokinetics of erythromycin 153
Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis 153
Enzyme inhibition and induction in liver disease. 151
Effect of herpes simplex virus type 1 infection on nucleoside transport in HeLa S3 cells 151
Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis 151
Penetration of carumonam into the pleural fluid: comparison of intravenous bolus and constant infusion in rats with experimentally induced pleurisy. 148
Pharmacokinetic drug interactions in liver disease: An update 142
Differential effect of liver cirrhosis on the pregnane X receptor-mediated induction of CYP3A1 and 3A2 in the rat. 140
A reassessment of the optimal sampling time for the MEGX liver function test 140
Further purification and characterization of the succinyl-CoA:3-hydroxy-3-methylglutarate coenzyme A transferase from rat-liver mitochondria. 138
Synergism between lysophosphatidylserine and the phorbol ester tetradecanoylphorbolacetate in rat mast cells. 135
Inhibition of cytochrome P450 2C8-mediated drug metabolism by the flavonoid diosmetin. 135
Pharmacokinetic characterization of phosphatidylserine liposomes in the rat 134
The effect of liver disease on inhibitory and plasma protein-binding displacement interaction:an update. 133
Fluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failure 133
Co-administration of sirolimus alters tacrolimus pharmacokinetics in a dose-dependent manner in adult renal transplant recipients 132
Reactivation of a phospholipid-depleted sodium, potassium-stimulated ATPase. 131
Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function 130
Effects of single dose of gamma-hydroxybutyric acid and lorazepam in psychomotor performance and subjective feelings in healthy volunteers 129
Pharmacokinetics of intraperitoneal cisplatin and doxorubicin 129
A COMPARATIVE-ANALYSIS OF THE URINARY-EXCRETION PROFILES OF MESNA AND ARGIMESNA FOLLOWING ORAL-ADMINISTRATION TO HEALTHY-VOLUNTEERS 127
Disposition kinetics of phospholipid liposomes. 123
Irreversible CYP3A Inhibition Accompained by Plasma Protein-Binding Displacement: A Comparative Analysis in Subjects with normal and impaired liver function. 122
Mechanism of local anesthetic effect. Involvement of F0 in the inhibition of mitochondrial ATP synthase by phenothiazines. 121
Influence of the mode of intravenous administration on the penetration of ceftazidime into tissues and pleural exudate of rats. 120
The role of residual phospholipids and copurified proteins in the reconstitution of bovine heart mitochondrial ATPase complex. 120
The effect of age on plasma MEGX concentrations. 120
Canrenone as a partial agonist at the digitalis receptor site of (Na+-K+)ATPase 119
Neoral versus Sandimmun in kidney-pancreas transplantation. 119
Liver dysfunction markedly decreases the inhibition of cytochrome P450IA2-mediated theophylline metabolism by fluvoxamine 118
Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity 117
Differential inducing effect of benzo[a]pyrene on gene expression and enzyme activity of cytochromes P450 1A1 and 1A2 in Sprague-Dawley and Wistar rats. 116
Role of antioxidant defences in the species-specific response of isolated atria to menadione 115
EFFECTS OF HERPES-SIMPLEX VIRUS TYPE-1 INFECTION ON THE PLASMA- MEMBRANE AND RELATED FUNCTIONS OF HELA S3 CELLS 114
F1-ATPase from different submitochondrial particles. 113
Nephrotoxic effect of atractyloside in rats. 113
Enzyme induction is independent on liver functional status 112
Liver dysfunction markedly decreases the inhibition of CYP1A2-mediated theophylline metabolism by fluvoxamine 111
Oral disposition kinetics of ofloxacin in patients with compensated liver cirrhosis. 111
Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis - Phase I study 111
The pharmacokinetics of teniloxazine in healthy subjects and patients with liver cirrhosis 110
Renal clearance of N(1)-methylnicotinamide: a sensitive marker of the severity of liver dysfunction in cirrhosis 110
Mechanism of Na+/K(+)-ATPase activation by trypsin and kallikrein. 110
Effect of gender on the monoethylglycinexylidide test in healthy subjects and patients with liver cirrhosis 109
Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. 109
Absorption and disposition kinetics of flunoxaprofen and benoxaprofen in healthy volunteers. 109
Protective action of cardiac DT-diaphorase against menadione toxicity in guinea pig isolated atria 108
The interaction of tricyclic antipsychotics with (Na+-K+)ATPase 108
Apomorphine-induced inhibition of histamine release in rat peritoneal mast cells. 107
Role of phosphatidylserine and phosphatidylcholine in the dicyclohexylcarbodiimide-induced inhibition of mitochondrial ATPase. 106
Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. 106
Effect of renal flailure on metabolic disposition of lidocaine in patients undergoing and not undergoing hemodialysis 105
Reduction of erythrocyte (Na+-K+)ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma. 98
Mechanism of inhibition of sodium- and potassium-dependent adenosine triphosphatase by tricyclic antipsychotics 97
Pharmacokinetics of miocamycin in patients with liver cirrhosis. 97
Renal clearance of N-1-Methylnicotinamide is a marker of liver dysfunction in cirrhosis 96
A new plot for multiple enzyme inhibition 95
Mechanism of local anesthetic effect on mitochondrial ATP synthase as deduced from photolabelling and inhibition studies with phenothiazine derivatives. 95
Reversal by phospholipids of the oligomycin induced inhibition of membrane associated adenosintriphosphatases. 94
Inhibition of protein kinase activity by apomorphine. 93
Effects of chronic renal failure and hemodialysis on the monoethylglycinexylidide liver function test. 91
Anion activation of dopamine beta-hydroxylase: a kinetic model. 90
Kinetic studies with competitive inhibitors indicate a sequential mechanism for dopamine beta-hydroxylase. 90
Needle and trocar injuries in diagnostic laparoscopy under local anesthesia: what is the true incidence of these complications? 89
In vitro inhibition of cytochrome P450 (CYP) 2C8-mediated drug metabolism by the flavonoid diosmetin 89
[Function of phospholipids in a membranous in a membranous complex with ATPase activity]. 84
A simple method for discriminating between full and partial inhibitors 83
Fumarate is the cause of the apparent ping-pong kinetics of dopamine beta-hydroxylase. 79
Mg-dependent inhibition of beef heart soluble mitochondrial ATPase by tricyclic antipsychotics 79
Evaluation ciprofloxacin and ofloxacin pharmacokinetics in liver cirrhosis. 78
Pharmacokinetic interactions between Tacrolimus and Sirolimus in Kidney Transplant recipients 78
The interaction between full and partial inhibitors acting on a single enzyme: a theoretical analysis 77
Evaluation of measured and calculated creatinine clearances as glomerular filtration markers in different stages of liver cirrhosis 74
Effect of experimentally induced liver cirrhosis on CYP3A induction in male Wistar rats 73
Interazioni farmacocinetiche tra Tacrolimus e Sirolimus nel Trapianto Renale 73
ORAL DISPOSITION KINETICS OF N-(AMINOSULPHONYL)-3-(((DIAMINOETHYLENE) AMINO)-N-THIAZOLYL) METHYLTHIOPROPANIMIDAMIDE (FAMOTIDINE) IN PATIENTS WITH LIVER-CIRRHOSIS 71
Effect of CYP 3A4 inhibition on lidocaine kinetics and the MEGS liver function test 70
Differential effect of liver dysfunction on CYP3A1 and CYP3A2 expression in rats with carbon tetrachloride-induced cirrhosis 69
Stereospecific disposition of flunoxaprofen enantiomers in human beings. 66
Inhibition of dopamine beta-hydroxylase by captopril. 66
Pharmacokinetics of gamma hydroxybutyric acid. 63
Effect of liver functional status on the pharmacokinetic interaction between the CYP 1A2 inhibitor fluvoxamine and lidocaine 62
Famotidine pharmacokinetics in the elderly: results of a preliminary study 58
Inhibition of enzymes and enzyme by phenothiazines and their radicals. In: Phenothiazienes and 1,4-benzothiazines 57
Serine phospholipids as endocoids. 55
Effect of moderate or severe liver dysfunction on the pharmacokinetics of gamma-hydroxybutyric acid 53
The behaviour of miocamycin kinetics in cirrhotic patients after single and repeated oral administration. 50
Totale 10.777
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.192
article - articoli 31.670
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 163
Totale 66.025
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021702 0 0 0 80 25 87 46 89 126 61 95 93
2021/20221.132 35 124 138 87 29 77 48 124 42 36 130 262
2022/2023951 177 132 11 103 166 137 10 59 108 6 30 12
2023/2024326 22 57 36 32 18 30 8 22 6 2 47 46
2024/20251.758 3 146 71 70 293 44 47 119 160 73 307 425
2025/20262.135 200 567 914 454 0 0 0 0 0 0 0 0
Totale 10.777